Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells von Zhao, Zeguo, Condomines, Maud, van der Stegen, Sjoukje J.C., Perna, Fabiana, Kloss, Christopher C., Gunset, Gertrude, Plotkin, Jason, Sadelain, Michel

Volltext

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma von Thayaparan, Thivyan, Petrovic, Roseanna M., Achkova, Daniela Y., Zabinski, Tomasz, Davies, David M., Klampatsa, Astero, Parente-Pereira, Ana C., Whilding, Lynsey M., van der Stegen, Sjoukje JC, Woodman, Natalie, Sheaff, Michael, Cochran, Jennifer R., Spicer, James F., Maher, John

Volltext

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling von Wilkie, Scott, van Schalkwyk, May C. I., Hobbs, Steve, Davies, David M., van der Stegen, Sjoukje J. C., Pereira, Ana C. Parente, Burbridge, Sophie E., Box, Carol, Eccles, Suzanne A., Maher, John

Volltext

Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4 von Wilkie, Scott, Burbridge, Sophie E., Chiapero-Stanke, Laura, Pereira, Ana C.P., Cleary, Siobhán, van der Stegen, Sjoukje J.C., Spicer, James F., Davies, David M., Maher, John

Volltext

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? von van der Stegen, Sjoukje J C, Davies, David M, Wilkie, Scott, Foster, Julie, Sosabowski, Jane K, Burnet, Jerome, Whilding, Lynsey M, Petrovic, Roseanna M, Ghaem-Maghami, Sadaf, Mather, Stephen, Jeannon, Jean-Pierre, Parente-Pereira, Ana C, Maher, John

Volltext

T cells fail to develop in the human skin-cell explants system; an inconvenient truth von Meek, Bob, Van Elssen, Catharina H M J, Huijskens, Mirelle J A J, van der Stegen, Sjoukje J C, Tonnaer, Siebe, Lumeij, Stijn B J, Vanderlocht, Joris, Kirkland, Mark A, Hesselink, Reinout, Germeraad, Wilfred T V, Bos, Gerard M J

Volltext

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin von Parente-Pereira, Ana C, Whilding, Lynsey M, Brewig, Nancy, van der Stegen, Sjoukje J C, Davies, David M, Wilkie, Scott, van Schalkwyk, May C I, Ghaem-Maghami, Sadaf, Maher, John

Volltext

Adoptive Immunotherapy of Epithelial Ovarian Cancer with V gamma 9V delta 2 T Cells, Potentiated by Liposomal Alendronic Acid von Parente-Pereira, Ana C, Shmeeda, Hilary, Whilding, Lynsey M, Zambirinis, Constantinos P, Foster, Julie, van der Stegen, Sjoukje JC, Beatson, Richard, Zabinski, Tomasz, Brewig, Nancy, Sosabowski, Jane K, Mather, Stephen, Ghaem-Maghami, Sadaf, Gabizon, Alberto, Maher, John

Volltext

Abstract 2309: T-cell development from T cell-derived induced pluripotent stem cell von van der Stegen, Sjoukje J.C., Themeli, Maria, Eyquem, Justin, Mansilla-Soto, Jorge, Sadelain, Michel

Volltext

Advancing river corridor science beyond disciplinary boundaries with an inductive approach to catalyse hypothesis generation von Ward, AS, Packman, A, Bernal, S, Brekenfeld, N, Drummond, J, Graham, E, Hannah, DM, Klaar, M, Krause, S, Kurz, M, Li, A, Lupon, A, Mao, F, Roca, MEM, Ouellet, V, Royer, TV, Stegen, JC, Zarnetske, JP

Volltext bestellen

Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state von Loon, Luc J. C., Koopman, René, Stegen, Jos H. C. H., Wagenmakers, Anton J. M., Keizer, Hans A., Saris, Wim H. M.

Volltext

Carbohydrate supplementation during prolonged cycling exercise spares muscle glycogen but does not affect intramyocellular lipid use von Stellingwerff, Trent, Boon, Hanneke, Gijsen, Annemie P, Stegen, Jos H C H, Kuipers, Harm, van Loon, Luc J C

Volltext

Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10 von WAGNER, S, STEGEN, C, BOUTERFA, H, HUETTNER, C, KERKAU, S, ROGGENDORF, W, ROOSEN, K, TONN, J.-C

Volltext

Inhibition Of Adipose Tissue Lipolysis Increases Intramuscular Lipid Use In Type 2 Diabetes Patients: 1417 4:15 PM ??? 4:30 PM von van Loon, Luc JC, Manders, Ralph JF, Koopman, Rene, Kaastra, Brechje, Stegen, Jos HCH, Gijsen, Annemie P., Saris, Wim HM, Keizer, Hans A.

Volltext

Inhibition Of Adipose Tissue Lipolysis Increases Intramuscular Lipid Use In Type 2 Diabetes Patients: 1417 4:15 PM – 4:30 PM von van Loon, Luc JC, Manders, Ralph JF, Koopman, Rene, Kaastra, Brechje, Stegen, Jos HCH, Gijsen, Annemie P., Saris, Wim HM, Keizer, Hans A.

Volltext